sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1262.

1 | 2 | 3 | 4 | 5 > >>

News Release 21-Sep-2020
Philosophical Transactions of the Royal Society B
How we age
It is well understood that mortality rates increase with age. Whether you live in Tokyo, rural Tennessee or the forests of Papua, New Guinea, the older you are, the more likely you are to succumb to any number of different ailments.

Contact: Andrea Estrada
andrea.estrada@ucsb.edu
805-893-4620
University of California - Santa Barbara

News Release 21-Sep-2020
Cell
Penn researchers discover potential cause of immunotherapy-related neurotoxicity
New research has uncovered the previously unknown presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB). This discovery may potentially be the cause for neurotoxicity in patients undergoing CD19 directed CAR T cell immunotherapy, according to the research team led by Avery Posey, PhD, an assistant professor of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania.
National Institutes of Health, Department of Veterans Affairs, Parker Institute for Cancer Immunotherapy, Scleroderma Research Foundation

Contact: Melissa Moody
melissa.moody@pennmedicine.upenn.edu
215-407-3536
University of Pennsylvania School of Medicine

News Release 21-Sep-2020
World Development
New research highlights impact of COVID-19 on food security in Kenya and Uganda
CABI scientists have conducted new research highlighting the impact of COVID-19 pandemic on food security in Kenya and Uganda with more than two-thirds of those surveyed having experienced economic hardship due to the pandemic. Dr Monica Kansiime led a team of researchers who discovered, from a random sample of 442 respondents, that the proportion of food insecure people increased by 38% and 44% in Kenya and Uganda respectively.

Contact: Wayne Coles
w.coles@cabi.org
0044-075-394-24817
CABI

News Release 21-Sep-2020
Bioarchaeology International
Archaeology uncovers infectious disease spread - 4000 years ago
New bioarchaeology research from a University of Otago PhD candidate has shown how infectious diseases may have spread 4000 years ago, while highlighting the dangers of letting such diseases run rife.

Contact: Craig Borley
craig.borley@otago.ac.nz
64-212-794-144
University of Otago

News Release 18-Sep-2020
Lancet Neurology
Mosquito-borne viruses linked to stroke
A deadly combination of two mosquito-borne viruses may be a trigger for stroke, new University of Liverpool research published in the The Lancet Neurology has found.

Contact: Nicola Frost
nicola.frost@liverpool.ac.uk
University of Liverpool

News Release 18-Sep-2020
Science Advances
Removal of a gene could render lethal poxviruses harmless
The removal of one gene renders poxviruses - a lethal family of viral infections that are known to spread from animals to humans - harmless, a new study in the journal Science Advances reports.

Contact: Natasha Meredith
n.meredith@surrey.ac.uk
07-706-838-630
University of Surrey

News Release 17-Sep-2020
Annals of Internal Medicine
COVID-19 news from Annals of Internal Medicine
1. Social distance proves key as respiratory route found to be the most common way to spread COVID-19 ; 2. Novel, rapidly deployable community isolation quarantine facilities help to manage COVID-19

Contact: Lauren Evans
laevans@acponline.org
215-351-2513
American College of Physicians

News Release 17-Sep-2020
EClinicalMedicine
Typhoid: Study confirms Vi-DT conjugate vaccine is safe and immunogenic in children 6-23 months
A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high rates of typhoid fever in resource-limited settings.
Bill & Melinda Gates Foundation

Contact: Aerie Em
aerie.em@ivi.int
International Vaccine Institute

News Release 16-Sep-2020
American Journal of Transplantation
Tailored education system to benefit kidney transplant patients
Researchers find their computer-tailored education system, 'Your Path to Transplant' increases knowledge and readiness to pursue kidney transplant.

Contact: Stewart Han
shan@terasaki.org
818-836-4393
Terasaki Institute for Biomedical Innovation

News Release 14-Sep-2020
'A World in Disorder'
The Global Preparedness Monitoring Board (GPMB), convened by the World Health Organization and the World Bank, today released Its new report, "A World in Disorder," the first independent preparedness report to be publicly issued during the COVID-19 pandemic. In its new report, the GPMB provides a harsh assessment of the global COVID-19 response, calling it "a collective failure to take pandemic prevention, preparedness, and response seriously and prioritize it accordingly."

Contact: Ned Berkowitz
ned.berkowitz@evokegroup.com
914-629-5157
Evoke KYNE

News Release 14-Sep-2020
BMJ Global Health
COVID-19 measures deepening health inequalities in slum communities
Efforts to stem the impact of COVID-19 in low to middle income countries could be creating a health time bomb in their slum communities by deepening existing inequalities, according to an international team of health researchers led by the University of Warwick.
National Institute for Health Research

Contact: Peter Thorley
peter.thorley@warwick.ac.uk
44-078-245-40863
University of Warwick

News Release 14-Sep-2020
Cell
Tiny antibody component highly effective against SARS-COV-2 in animal studies
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller than a full-sized antibody, has been used to construct a drug - known as Ab8 - for potential use as a therapeutic and prophylactic against SARS-CoV-2.
National Institutes of Health, UPMC, Burroughs Wellcome Fund, Canada Excellence Research Chair Award, Genome BC

Contact: Allison Hydzik
HydzikAM@upmc.edu
412-559-2431
University of Pittsburgh

News Release 11-Sep-2020
Annals of Internal Medicine
COVID-19 news from Annals of Internal Medicine
Counts based on death certificates underestimate COVID-19 mortality rates.

Contact: Lauren Evans
laevans@acponline.org
215-351-2513
American College of Physicians

News Release 10-Sep-2020
Proceedings of the National Academy of Sciences
Human norovirus strains differ in sensitivity to the body's first line of defense
Human norovirus strains differ in sensitivity to interferon, one of the body's first line of defense.

Contact: Dipali Pathak
pathak@bcm.edu
713-798-4710
Baylor College of Medicine

News Release 9-Sep-2020
Vaccine X
For an effective COVID vaccine, look beyond antibodies to T-cells
Most vaccine developers are aiming solely for a robust antibody response against the SARS-CoV-2 virus, despite evidence that antibodies are not the body's primary protective response to infection by coronaviruses, says Marc Hellerstein of UC Berkeley. The hallmark of a good, long-lasting vaccine is a robust T-cell response. Labelling techniques can quickly measure the longevity of T-cells against the coronavirus, and should be employed to assess vaccines' T-cell responses before approval to ensure effective protection.

Contact: Robert Sanders
rlsanders@berkeley.edu
510-915-3097
University of California - Berkeley

News Release 9-Sep-2020
The Lancet Global Health
The Lancet Global Health: Modelling study estimates health-care cost of COVID-19 in low- and middle-income countries at US$52 billion every four weeks
New modelling research, published in The Lancet Global Health journal, estimates that it could cost low- and middle-income countries (LMICs) around US$52 billion (equivalent to US$8.60 per person) over four weeks to provide an effective health-care response to COVID-19, assuming each country's reproductive number (average number of contacts that a case infects) remained unchanged (table 2).

Contact: Lancet Press Office
pressoffice@lancet.com
44-020-742-44249
The Lancet

News Release 9-Sep-2020
IVI to ready clinical trial sites for COVID-19 vaccine efficacy trials in 4 countries
The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.
Bill & Melinda Gates Foundation

Contact: Aerie Em
aerie.em@ivi.int
International Vaccine Institute

News Release 9-Sep-2020
Lancet Planetary Health
Stanford researchers anticipate rise of some mosquito-borne diseases
A warming climate and urbanization will likely lower rates of malaria, while increasing rates of other mosquito-borne diseases, such as dengue fever, in Sub-Saharan Africa. Public health strategies must adapt to avoid a public health crisis. Watch related video: https://www.youtube.com/watch?v=DaVJbYPxXhs
National Institutes of Health, Maternal & Child Health Research Institute, National Science Foundation, Hellman Fellows Fund, Stanford University Terman Fellowship, Stanford Woods Institute for the Environment, Centers for Disease Control and Prevention

Contact: Rob Jordan
rjordan@stanford.edu
650-721-1881
Stanford University

News Release 7-Sep-2020
Scientific Reports
Distribution range of Ebola virus carriers in Africa may be larger than previously assumed
Zaire ebolavirus is among the deadliest of all known Ebola viruses for humans and is most likely transmitted by various species of bats. Models recently developed by scientists of the Senckenberg Nature Research Society and the Goethe University in Frankfurt show where these species may thrive in Africa. The results of the study, published in the journal "Scientific Reports", suggest a wider range of distribution for the bat and fruit bat species than previously assumed.

Contact: Prof. Dr. Sven Klimpel
sven.klimpel@senckenberg.de
49-697-984-2237
Goethe University Frankfurt

News Release 4-Sep-2020
The Lancet
The Lancet: Preliminary results from Russian trials find that vaccine candidates led to no serious adverse events and elicit antibody response
Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.

Contact: Lancet Press Office
pressoffice@lancet.com
44-020-742-44249
The Lancet

News Release 4-Sep-2020
American Journal of Clinical Nutrition
Factors that raise the risk of mortality among children with several acute malnutrition
#AJCN review identifies independent predictors of inpatient mortality among children with severe acute malnutrition: HIV infection, diarrhea, pneumonia, shock, lack of appetite, and low weight-to-height ratio. The authors found that children with a low weight-to-height ratio at hospital admission were at highest risk of mortality. "Early recognition of these prognostic factors within the community, alongside risk stratification at hospital admission, may help reduce inpatient mortality among children with severe acute malnutrition," said author Jonathan Sturgeon.
Wellcome Trust

Contact: OUP Journals Publicity team
journals.publicity@oup.com
American Society for Nutrition

News Release 3-Sep-2020
The Lancet
The Lancet: Many countries falling behind on global commitments to tackling premature deaths from chronic diseases, such as diabetes, lung cancer and heart disease
Around the world, the risk of dying prematurely from preventable and largely treatable chronic diseases such as stroke, heart disease, and stomach cancer has declined steadily over the past decade, but death rates from other chronic diseases such as diabetes, lung cancer, colon cancer, and liver cancer are declining too slowly or worsening in many countries.

Contact: Lancet Press Office
pressoffice@lancet.com
44-020-742-44249
The Lancet

News Release 3-Sep-2020
Annals of Emergency Medicine
Innovative biocontainment unit shows promise to protect healthcare workers
The U.S. Army partnered with the University of Pittsburg Medical Center to create a biocontainment unit that could help healthcare workers caring for COVID-19 patients. Researchers from the U.S. Army Combat Capabilities Development Command's Army Research Laboratory and UPMC created an individual biocontainment unit that uses negative pressure to suction the air from around a patient and filter out viral particles. This prevents environmental contamination and limits exposure to SARS-CoV-2.

Contact: Joyce M. Conant
joyce.m.conant2.civ@mail.mil
443-221-9801
U.S. Army Research Laboratory

News Release 3-Sep-2020
Frontiers in Bioengineering and Biotechnology
Wearable, portable invention offers options for treating antibiotic-resistant infections
About 6 million people in the United States are affected by chronic wounds. Now, a team of innovators from Purdue University has developed a wearable solution that allows a patient to receive treatment without leaving home.

Contact: Chris Adam
cladam@prf.org
Purdue University

News Release 3-Sep-2020
Communications Biology
Safe thresholds for antibiotics in sewage needed to help combat antibiotic resistance
New research reveals current understanding of safe antibiotic levels in rivers may not prevent evolution of antibiotic resistance and fully protect human health. The study suggests the need to introduce thresholds to help fight the spread of resistant bacteria.
Biotechnologyand Biological Sciences Research Council, AstraZeneca, Natural Environment Research Council

Contact: Louise Vennells
l.vennells@exeter.ac.uk
44-776-851-1866
University of Exeter

Showing releases 1-25 out of 1262.

1 | 2 | 3 | 4 | 5 > >>